
Rheumatology
Latest News

August 19th 2019
By Kelly Davio
Biologics have become the standard of care for rheumatoid arthritis (RA) that fails to respond adequately to conventional disease-modifying antirheumatic agents (DMARDs), and overall, these agents are safe and effective. However, an association between treatment with anti–tumor necrosis factor (anti-TNF) agents and new-onset psoriasis in patients with RA has been observed.
Advertisement
CME Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
2
Government Shutdown Concluded but ACA Subsidies in Limbo
3
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5






































































